Download full report with analyst certification and important disclosures
Dec 15 2021, 09:50 GMT
Foods
ADM Nutrition – an emerging force in Ingredients with punchy growth targets
- Sectors : Foods
- Companies : Givaudan | Kerry Group | Symrise | DSM-Firmenich
Ratings
Ratings and price correct at time of issue
| Company | Rating | Date | Previous Rating | Date | Closing Price |
|---|---|---|---|---|---|
| DSM-Firmenich | OUTPERFORM | 09/10/20 | Neutral | 13/02/20 | 19490c |
| Givaudan | OUTPERFORM | 24/03/20 | Neutral | 21/06/12 | 471800chf |
| Kerry Group | OUTPERFORM | 30/06/09 | N/A | N/A | 11330c |
| Symrise | OUTPERFORM | 24/03/20 | Neutral | 15/01/19 | 12905c |
DAVY VIEW
ADM’s recent investor day confirmed that it is a name to watch in the Ingredients space as it delineated the next phase of growth in its Nutrition division (which straddles the human, animal and pet market). ADM has leveraged its investment and acquisition portfolio to accelerate the business to the vanguard of sector growth. The next phase of ADM’s growth strategy focuses on positioning ADM Nutrition into areas of secular growth while congruently expanding its capacity through continued investment. From FY21, ADM Nutrition is targeting average annual revenue growth of c.10% per annum with operating profit targeted to almost double by FY25.
